AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Market Cap	12.52B +5.9%
Revenue (ttm)	32.89B +2.0%
Net Income	1.37B -8.3%
EPS	96.23 -9.2%
Shares Out	14.56M
PE Ratio	8.94
Forward PE	n/a
Dividend	36.00 (4.19%)
Ex-Dividend Date	Aug 28, 2026

Volume	16,700
Average Volume	24,065
Open	861.00
Previous Close	861.00
Day's Range	859.00 - 865.00
52-Week Range	835.00 - 918.00
Beta	n/a
RSI	39.10
Earnings Date	Jul 15, 2026

About AFC-HD AMS Life Science

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and supplements. It plans, researches, develops, and processes, as well as completes dietary supplement and cosmetics. The company offers health foods in various forms, such as tablets, soft and hard capsules, granules, soft drinks, and jellies. Its cosmetic products include facial cleansing, lotions, milky lotions, makeup oils, cleansing creams, and liquid cosmetics.. The company also wholesales dietary supplements and cosmetics; collects health-re...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1969
• Employees: 1,008
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2927

Financial Performance

In fiscal year 2025, AFC-HD AMS Life Science's revenue was 32.66 billion, an increase of 8.18% compared to the previous year's 30.19 billion. Earnings were 1.45 billion, an increase of 15.65%.